Clinical Trial Update: GnRH Agonist Administration in the Luteal Phase of ICSI-ET Cycles [NA]

View source ↗

Summary

This clinical trial update reports on administering a GnRH agonist during the luteal phase in ICSI-ET cycles for infertility. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• GnRH agonist (gonadotropin-releasing hormone agonist)

Snippet

Sponsor: V.K.V. American Hospital, Istanbul | Conditions: Infertility | NA | Status: COMPLETED